Jobs
-
Enterprise Therapeutics announced that a Phase 2 trial of ETD001, an inhaled epithelial sodium channel blocker, met its primary endpoint, demonstrating a statistically significant and clinically relevant improvement in lung function versus placebo after 28… Read more . . .
-
According to Chance Pharmaceuticals, China’s National Medical Products Administration has accepted the company’s NDA for CXG87 budesonide / formoterol DPI for the treatment of asthma. The announcement emphasizes that the formulation is Chance’s own “improved… Read more . . .
-
CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing… Read more . . .
-
CDMO Intertek has announced an expansion of a GMP stability storage facility near Cambridge, UK, noting that the expanded facility offers custom temperature and relative humidity conditions and is suitable for stability testing of a… Read more . . .
-
As RDD 2026 is about to get underway in Phoenix, AZ, USA, some of the meeting sponsors and exhibitors are previewing their conference activities. As always, RDD is sponsored by dozens of organizations that offer… Read more . . .
-
MannKind Corporation announced that it is developing a DPI formulation of MNKD-1501 ralinepag for the treatment of pulmonary arterial hypertension under an agreement with United Therapeutics under a 2018 licensing and collaboration agreement between the companies that… Read more . . .
-
UK-based inhaler developer Merxin Ltd has been awarded a 2026 King’s Award for Enterprise for Innovation, the company announced. Merxin, which is headquartered in King’s Lynn, UK, was launched in 2015 . The award announcement… Read more . . .
-
Copley Scientific has announced the launch of its SRS 100i automated sample recovery system for use with delivered dose uniformity and APSD testing set-ups, including the compendial dose uniformity sample apparatus (DUSA), the Next Generation Impactor (NGI),… Read more . . .
-
3P innovation, which makes filling systems for dry powder inhaler blisters, and Mikron Automation, which offers device assembly systems, announced that they have partnered to provide integrated manufacturing systems for blister-based DPIs. The companies say that… Read more . . .
-
Insilico Medicine, which has facilities in the US and China, said that an IND for a Phase 1 PK trial of rentosertib (ISM001-055) inhalation solution has been cleared by the CDE. The company said that… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.